Influence
September 11, 2025

Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States

Regenstrief Research Scientist Wanzhu Tu, PhD

Published in the Journal of Hepatology. Here is a link to the article. 

Regenstrief Institute author: Wanzhu Tu, PhD.

A new study analyzing national mortality data found that deaths from liver disease have increased in recent years, with the highest growth seen among adults under the age of 55. 

The analysis, which reviewed data from 1988 to 2019, showed that alcohol-associated liver disease accounted for the largest portion of deaths and experienced the fastest rate of increase. Nonalcoholic fatty liver disease was also identified as a steadily growing cause of liver-related deaths. 

After a period of stability, overall liver disease mortality began rising again starting in the mid-2000s, with a sharper increase observed between 2010 and 2019. The data indicate a shift in the burden of liver disease toward younger adults, emphasizing the importance of early identification and monitoring. 

The study provides updated national trends and identifies alcohol-associated and nonalcoholic fatty liver disease as the primary contributors to the recent increase in liver-related deaths. These findings can help guide future research, healthcare planning and prevention initiatives. 

Authors: 

Eduardo Vilar-Gomez1, Lauren Nephew1, Samer Gawrieh1, Raj Vuppalanchi1, Carla Kettler2, Francis Pike2, Wanzhu Tu2, Niharika Samala1, Suthat Liangpunsakul1,3, Naga Chalasani1   

Affiliations  

1Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA 

2Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA 

3Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA 

Partners

Related News

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released